Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

CACCIAPAGLIA, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.478
SA - Sud America 1.090
NA - Nord America 742
EU - Europa 205
AF - Africa 148
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 3.667
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 844
US - Stati Uniti d'America 701
VN - Vietnam 538
SG - Singapore 407
CN - Cina 316
AR - Argentina 104
MA - Marocco 99
EC - Ecuador 49
ID - Indonesia 45
IT - Italia 40
HK - Hong Kong 36
PK - Pakistan 29
CO - Colombia 28
FR - Francia 28
BD - Bangladesh 27
RU - Federazione Russa 24
DE - Germania 22
PY - Paraguay 22
ZA - Sudafrica 22
MX - Messico 19
GB - Regno Unito 17
UA - Ucraina 16
IN - India 13
IQ - Iraq 12
PL - Polonia 12
CL - Cile 11
NL - Olanda 10
PE - Perù 10
UY - Uruguay 10
VE - Venezuela 10
EG - Egitto 8
AT - Austria 7
SY - Repubblica araba siriana 7
AZ - Azerbaigian 5
CA - Canada 5
GT - Guatemala 5
NP - Nepal 5
SE - Svezia 5
UZ - Uzbekistan 5
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
TN - Tunisia 4
TR - Turchia 4
CG - Congo 3
IE - Irlanda 3
KE - Kenya 3
KG - Kirghizistan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
DZ - Algeria 2
ES - Italia 2
FI - Finlandia 2
HN - Honduras 2
IR - Iran 2
JO - Giordania 2
JP - Giappone 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AL - Albania 1
AU - Australia 1
BW - Botswana 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
HR - Croazia 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
KW - Kuwait 1
ML - Mali 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SV - El Salvador 1
Totale 3.667
Salva come PNG Salva come JPEG
Città #
Dallas 285
Ho Chi Minh City 197
Singapore 192
Ashburn 108
Hanoi 106
Hefei 104
Casablanca 93
The Dalles 81
São Paulo 67
Hong Kong 36
San Jose 34
Rio de Janeiro 30
Da Nang 26
Islamabad 26
Boydton 25
Hillsboro 23
Hải Dương 18
Guayaquil 17
Haiphong 17
Curitiba 16
Biên Hòa 14
Quito 14
Beijing 13
Ribeirão Preto 13
Thái Bình 13
Warsaw 12
New York 11
Porto Alegre 11
Teresina 11
Brasília 10
Can Tho 9
Fortaleza 9
Lấp Vò 9
Rio Bonito 9
Sorocaba 9
Frankfurt am Main 8
Montevideo 8
Phủ Lý 8
Salvador 8
Viamão 8
Asunción 7
Atibaia 7
Bari 7
Belo Horizonte 7
Campinas 7
Chicago 7
Goiânia 7
Johannesburg 7
Los Angeles 7
Ninh Bình 7
Pelotas 7
Rome 7
Avellaneda 6
Bogotá 6
Bắc Ninh 6
Feira de Santana 6
Guarulhos 6
Manaus 6
Naucalpan 6
Orem 6
Quảng Ngãi 6
Thái Nguyên 6
Amsterdam 5
Baghdad 5
Barnet 5
Buenos Aires 5
Bắc Giang 5
Cape Town 5
Dhaka 5
Jakarta 5
Lima 5
Limburg an der Lahn 5
Milan 5
Ourinhos 5
Pindamonhangaba 5
Santiago de Cali 5
Santo André 5
St Petersburg 5
Vĩnh Tường 5
Bauru 4
Brooklyn 4
Cairo 4
Caracas 4
Catania 4
Chennai 4
Concepción 4
Cuenca 4
Gravatá do Ibiapina 4
Ha Long 4
Hortolândia 4
Huế 4
Itaquaquecetuba 4
João Pessoa 4
Kathmandu 4
Natal 4
Nova Iguaçu 4
Petrolina 4
Quảng Ninh 4
Seattle 4
São Gonçalo 4
Totale 2.021
Salva come PNG Salva come JPEG
Nome #
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases 55
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort 54
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis 54
Adherence to the 2019 ESC/EAS guidelines for dyslipidaemia management in a large rheumatoid arthritis cohort: Data from the CORDIS Study Group of the Italian Society of Rheumatology 53
Atherosclerosis and Autoimmunity 52
Clinical Features of Diabetes Mellitus on Rheumatoid Arthritis: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 51
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis 50
Apoptotic molecular mechanisms implicated in autoimmune diseases 50
APOPTOSIS AND AUTOIMMUNITY INDUCED BY CLODRONATE IN SYSTEMIC LUPUS ERYTHEMATOSUS MONONUCLEAR CIRCULATING CELLS 49
Complete Hydatidiform Mole Mimicking Sacroiliitis 48
Alexithymia and neuroendocrine-immune response in patients with autoimmune diseases: preliminary results on relationship between alexithymic construct and TNF-alpha levels 45
Rituximab retention rate in systemic sclerosis: a long term real-life multicenter study 45
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments. 45
Antinuclear antibodies prevalence in Filipinos migrated to Italy 44
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues 44
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 44
Body mass index and adipokines/cytokines dysregulation in systemic sclerosis 44
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group. 43
Influence of TNF-alpha inhibition on oxidative stress of rheumatoid arthritis patients 43
The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement 43
Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients 42
Effectiveness of tapering rituximab dose in idiopathic inflammatory myopathies: Real-world data from a monocentric study 42
Spontaneous splenorenal shunt in a patient with antiphospholipid syndrome: the first case reported 42
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 42
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents 41
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry 41
Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis 41
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life 40
The natural history of insulin content in the pancreas of female and mate non-obese diabetic mouse: implications for trials of diabetes prevention in humans 40
Inflammation and iron metabolism in adult patients with epilepsy: Does a link exist? 40
Lipid Profile of Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Drugs Changes According to Disease Activity and Predicts Clinical Response 39
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort 39
Effectiveness of biological targeted therapies may discriminate seronegative from seropositive rheumatoid arthritis 39
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 39
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 38
Traditional and non traditional risk factors in accelerated atherosclerosis in Systemic Lupus Erythematosus: Role of vascular endothelial growth factor (VEGATS Study) 38
Postmeal portal flow variations in HCV-related chronic hepatitis and liver cirrhosis with and without hyperdynamic syndrome 38
Italian recommendations for the assessment of cardiovascular risk in rheumatoid arthritis: a position paper of the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group of the Italian Society for Rheumatology 38
Sex Differences in Cardiovascular Risk Profiles of Patients with Rheumatoid Arthritis: Results from an Italian Multicentre Cohort 38
Serum adiponectin levels are associated with presence of carotid plaque in women with systemic lupus erythematosus. 37
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrum. 37
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 37
Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al' by Agca et al 37
Janus kinase inhibitors: between prescription authorization and reimbursability 37
Serum sCD40L levels are increased in patients with psoriatic arthritis and are associated with clinical response to apremilast. 37
Adipokines and Systemic Lupus Erythematosus: Relationship with Metabolic Syndrome and Cardiovascular Disease Risk Factors 37
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 37
The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement 36
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 36
Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre 36
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 36
Possible role of adipocytokines in systemic sclerosis-associated small pericardial effusion 36
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE) 36
Pulmonary and extra-pulmonary effects of lung transplantation in an Italian cohort of patients with systemic sclerosis 35
Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies 35
Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse 35
Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy 35
Tumour necrosis factor alpha (TNFα) cardiomyocyte preconditioning: Clues to explain anti-TNFα agents contraindication in severe heart failure 34
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus 34
COVID-19 vaccine immunogenicity in 16 patients with autoimmune systemic diseases. Lack of both humoral and cellular response to booster dose and ongoing disease modifying therapies 34
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 34
Matters of the Heart: The Case of TNF alpha-Targeting Drugs 34
Effective tumour necrosis factor-blocking therapy reduces reactive oxygen metabolite level in rheumatoid arthritis 34
Survival and Prognostic factors from a multicentre large cohort of unselected Italian Systemic Sclerosis patients 34
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients. 33
Disease activity assessment for juvenile idiopathic arthritis in transitional care 33
Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registry 33
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 33
The natural history of insulin content in the pancreas of female and male non-obese diabetic mouse: implication for trials of diabetes prevention in humans 32
Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse 32
Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey 32
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis 32
The use of a glucose spray device to control progression towards hypoglycaemia 32
Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment 32
Portosystemic shunts in a large cohort of patients with liver cirrhosis: detection rate and clinical relevance 32
Predictors of long-term clinical remission in rheumatoid arthritis 32
Pulmonary arterial hypertension: guidelines and unmet clinical needs. 32
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 31
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 31
IL TUTORATO D'AULA 31
Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus 31
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 31
Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment 31
Response to: 'Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al' by Agca et al. 31
Serum osteopontin negatively impacts on intima-media thickness in patients with systemic lupus erythematosus 30
Thoracic lymphadenopathy as possible predictor of the onset of interstitial lung disease in systemic sclerosis patients without lung involvement at baseline visit: A retrospective analysis 30
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort 30
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis 29
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 29
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry. 29
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA. 28
Phosphorylated signal transducer and activator of transcription 3 (pSTAT3) is highly expressed in CD14+ circulating cells of scleroderma patients 28
Low Level Tumor Necrosis Factor-Alpha Protects Cardiomyocytes Against High Level Tumor Necrosis Factor-Alpha: Brief Insight into a Beneficial Paradox 28
The Use of an Interferon-Gamma Release Assay as a Biomarker of Response to Anti-TNF-Alpha Treatment 28
Successful treatment with anakinra of refractory pericarditis in systemic lupus erythematosus 28
Subcutaneous immunoglobulin therapy for refractory skin thickening in rapidly progressive systemic sclerosis: A case report and literature review 27
Varicella-zoster virus infection in rheumatoid arthritis patients in the anti-tumour necrosis factor era 27
Safety profile and low risk of disease relapse after BNT162b2 mRNA SARS-COV-2 vaccination in patients with rare rheumatic diseases 27
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases 25
Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection 24
Totale 3.687
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.546
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025462 0 0 0 120 24 97 28 17 46 24 77 29
2025/20263.309 47 312 775 1.368 73 51 202 255 103 123 0 0
Totale 3.771